• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis.

作者信息

Moey Melissa Y Y, Gougis Paul, Goldschmidt Vincent, Johnson Douglas B, Lebrun-Vignes Bénédicte, Moslehi Javid, Cadranel Jacques, Salem Joe-Elie

机构信息

Dept of Cardiovascular Sciences, Vidant Medical Center/East Carolina University, Greenville, NC, USA.

Dept of Pharmacology, INSERM CIC-1901, UNICO-GRECO Cardio-oncology Program, CLIP2 Galilée, APHP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.

出版信息

Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00038-2020. Print 2020 Jun.

DOI:10.1183/13993003.00038-2020
PMID:32079644
Abstract
摘要

相似文献

1
Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis.免疫检查点抑制剂相关致命性肺炎报告增加：世界卫生组织药物警戒数据库分析
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00038-2020. Print 2020 Jun.
2
Immune Checkpoint Inhibitors and Venous Thromboembolism: An Analysis of the WHO Pharmacovigilance Database.免疫检查点抑制剂与静脉血栓栓塞症：世卫组织药物警戒数据库分析。
Clin Pharmacol Ther. 2022 Jul;112(1):164-170. doi: 10.1002/cpt.2615. Epub 2022 May 2.
3
Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.免疫检查点抑制剂时代药物性葡萄膜炎谱的演变来自世卫组织的药物警戒数据库。
J Autoimmun. 2020 Jul;111:102454. doi: 10.1016/j.jaut.2020.102454. Epub 2020 Apr 14.
4
Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.使用日本药物不良反应报告数据库分析免疫检查点抑制剂引起的免疫相关不良事件。
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1279-1294. doi: 10.1002/pds.5108. Epub 2020 Sep 1.
5
Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.药物警戒学的启示：免疫检查点抑制剂治疗后的肺部免疫相关不良事件。
Lung. 2021 Apr;199(2):199-211. doi: 10.1007/s00408-021-00425-x. Epub 2021 Feb 22.
6
The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis.与免疫检查点抑制剂相关的肺炎的相关风险因素。
Oncology. 2021;99(4):256-259. doi: 10.1159/000512633. Epub 2021 Jan 21.
7
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.免疫检查点阻断相关的类固醇难治/抵抗性肺炎中额外免疫调节剂的成败。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001884.
8
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitors.免疫检查点抑制剂引起的类固醇抵抗/难治性肺炎的发生率和结局。
Respir Med Res. 2022 Nov;82:100969. doi: 10.1016/j.resmer.2022.100969. Epub 2022 Nov 9.
9
Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.瑞士的药物性肝损伤：来自 2010 年至 2020 年世界卫生组织药物警戒数据库 VigiBase的与药物相关的肝障碍分析。
Swiss Med Wkly. 2021 May 12;151:w20503. doi: 10.4414/smw.2021.20503. eCollection 2021 May 10.
10
Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study.免疫检查点抑制剂相关的急性肾损伤：一项药物警戒研究。
Int Immunopharmacol. 2022 Dec;113(Pt A):109350. doi: 10.1016/j.intimp.2022.109350. Epub 2022 Oct 20.

引用本文的文献

1
Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.免疫检查点抑制剂在妊娠期的应用及其对妊娠个体和新生儿结局的影响。
JAMA Netw Open. 2024 Apr 1;7(4):e245625. doi: 10.1001/jamanetworkopen.2024.5625.
2
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.免疫检查点阻断治疗后立即接受后续治疗的患者的抗肿瘤治疗引起的间质性肺病的泛癌评估。
Respir Res. 2024 Jan 10;25(1):25. doi: 10.1186/s12931-024-02683-8.
3
Associations between HIFs and tumor immune checkpoints: mechanism and therapy.
低氧诱导因子与肿瘤免疫检查点之间的关联：机制与治疗
Discov Oncol. 2024 Jan 2;15(1):2. doi: 10.1007/s12672-023-00836-7.
4
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.针对 ERBB2 的妊娠治疗及妊娠个体和新生儿结局。
JAMA Netw Open. 2023 Oct 2;6(10):e2339934. doi: 10.1001/jamanetworkopen.2023.39934.
5
A case report and literature review of immune checkpoint inhibitor-associated pneumonia caused by penpulimab.信迪利单抗相关免疫检查点抑制剂肺炎 1 例报告并文献复习
Front Immunol. 2023 Jun 22;14:1114994. doi: 10.3389/fimmu.2023.1114994. eCollection 2023.
6
Updates in toxicities associated with immune checkpoint inhibitors.免疫检查点抑制剂相关毒性的最新进展。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(9):1117-1129. doi: 10.1080/1744666X.2023.2221434. Epub 2023 Jun 5.
7
Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report.病例报告：尼达尼布治疗SMARCA4突变型非小细胞肺癌患者抗PD-1治疗引发的免疫相关性肺炎：一例病例报告
Front Pharmacol. 2023 May 4;14:1177329. doi: 10.3389/fphar.2023.1177329. eCollection 2023.
8
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validation.免疫治疗联合常规疗法相关间质性肺炎：基于真实世界数据验证的药物警戒数据库分析。
BMC Med. 2023 Jan 5;21(1):6. doi: 10.1186/s12916-022-02713-6.
9
Diagnostic and therapeutic approach to pulmonary infiltrates in cancer patients receiving immune checkpoint inhibitors.免疫检查点抑制剂治疗的癌症患者肺部浸润的诊断和治疗方法。
Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):67-73. doi: 10.37201/req/s03.15.2022. Epub 2022 Oct 24.
10
Harnessing big data to characterize immune-related adverse events.利用大数据来描述免疫相关不良事件。
Nat Rev Clin Oncol. 2022 Apr;19(4):269-280. doi: 10.1038/s41571-021-00597-8. Epub 2022 Jan 17.